Target intelligence / Profile preview

Trained innate immunity

Molecular classification
Other
01

Overview

Trained innate immunity (or simply "trained immunity") describes a phenomenon where innate immune cells such as monocytes, macrophages, and natural killer cells acquire a long-lived, enhanced response to secondary infections or stimuli, due to epigenetic and metabolic reprogramming[1][4][7][16]. Unlike adaptive immunity, trained innate immunity is non-specific and does not involve antigen-specific receptors or memory cells, but instead results from prior exposure to certain infections, vaccines, or endogenous signals that alter chromatin structure and gene expression, leading to heightened inflammatory potential when cells are restimulated[1][7][4][10]. This process is implicated in both protection against unrelated infections and in the pathogenesis of chronic inflammatory and autoimmune diseases, as well as organ transplant rejection when dysregulated[1][7]. Clarification: "Trained innate immunity" is not a specific molecule, receptor, or canonical therapeutic target, but rather a functional and epigenetic state of the innate immune system[1][7][4]. The query does not refer to a druggable protein, enzyme, transporter, or receptor, and thus should be flagged as not a discrete drug target (is_target: false; is_incorrect: true).

Other names
Trained immunityInnate immune memoryInnate immune training
02

Biological functions

Immune responseEpigenetic reprogrammingInflammatory signaling
03

Disease associations

InfectionInflammationAutoimmunityOrgan transplantation
04

Safety considerations

Aberrant inflammation when wrongly activatedPossible contribution to autoimmune disease and transplant rejection

Beyond the preview

Go deeper on Trained innate immunity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trained innate immunity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call